Hepcinat plus tablet contains active agents Daclatasvir and Sofosbuvir. It is an antiviral medication used to treat chronic hepatitis C virus (HCV) infections. Hepatitis C infection is a liver disease caused by the hepatitis C virus (HCV). Talk to your doctor if you have liver problems other than hepatitis C infection, had a liver transplant, diabetes, heart disorders, severe kidney problems, or are on dialysis before taking Hepcinat plus tablet. Your physician will perform blood tests to check for hepatitis B virus infection before starting treatment with this medicine, as this medicine can reactivate the hepatitis B virus. Hepatitis B virus reactivation can cause serious liver problems and liver failure. It is vital to inform your doctor if you are taking or have taken any medication for heart problems in the past months. Elderly patients may be more susceptible to the side effects of Hepcinat plus tablet and may require lower doses or closer monitoring during treatment. The safety and effectiveness of pediatric patients have not been established. These medications should only be used in children under the guidance of a pediatric specialist.
Send Message